Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in Platinum-Resistant Ovarian Cancer
NCT00499252Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jun 2007
- Primary completion
- Jul 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in ovarian epithelial cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by GOG Foundation. Started Jun 2007; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
ovarian epithelial cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00499252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499252.